Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents by Citrome L

Get full text

Role of sublingual asenapine in treatment of schizophrenia by Citrome L

Get full text

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy by Citrome L

Get full text

Schizophrenia relapse, patient considerations, and potential role of lurasidone by Citrome L

Get full text

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults by Faden J, Citrome L

Get full text

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy by Ward K, Citrome L

Get full text

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm by Citrome L, Du Y, Weiden PJ

Get full text

Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies by Rosenberg R, Citrome L, Drake CL

Get full text

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder by Citrome L, Landbloom R, Chang C, Earley W

Get full text

Tardive Dyskinesia in Older Persons Taking Antipsychotics by Citrome L, Isaacson SH, Larson D, Kremens D

Get full text

Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis by Citrome L, Castelli M, Hasebe M, Terahara T, Faden J, Komaroff M

Get full text

Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians by Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD

Get full text

Impact of Demographics and Insurance Coverage on Schizophrenia Treatment and Healthcare Resource Utilization Within an Integrated Healthcare System by Seo S, Healey BE, McLin R, Sacks NC, Benson CJ, Citrome L

Get full text

Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review by Brubaker M, Kapadia S, Maletic V, Chambers JS, Watling CP, Citrome L

Get full text

Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study by Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD

Get full text

The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness. by Dursun, S, Wildgust, H, Strickland, P, Goodwin, G, Citrome, L, Lean, M

What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends by Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL, Gregg M

Get full text

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future by Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ

Get full text

Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best–Worst Scaling Results by Bridges JFP, Goldberg JF, Fitzgerald HM, Chumki SR, Beusterien K, Will O, Citrome L

Get full text

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations by Jackson R, Brams MN, Citrome L, Hoberg AR, Isaacson SH, Kane JM, Kumar R

Get full text